Cervical cancer: the sub-Saharan African perspective

References

• DM Parkin, J Ferlay, M Hamdi-Cherif. Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications. No.153. 2003; IARC Press: Lyon.
   Google Scholar
• DM Parkin, SL Whelan, J Ferlay. Cancer Incidence in Five Continents, Vol VIII. IARC Scientific Publication No.155. 2002; IARC: Lyon.
   Google Scholar
• HR Wabinga, DW Parkin, F Wabwire-Mangen. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. British Journal of Cancer. 82(9): 2000; 1585–1592.
   PubMed Web of Science ®Google Scholar
• E Chokunonga, LM Levy, MT Bassett. Zimbabwe cancer registry. DM Parkin, SL Whelan, J Ferlay. Cancer Incidence in Five Continents. Vol. VIII. 2002; IARC Press: Lyon, 104–105.
   Google Scholar
• ARP Walker, PM Michelow, BF Walker. Cervix cancer in African women in Durban, South Africa. International Journal Gynecology & Obstetrics. 79: 2002; 45–46.
   Web of Science ®Google Scholar
• R Sankaranarayanan, J Ferlay. Worldwide burden of gynaecological cancer: the size of the problem. Best Practice and Research Clinical Obstetrics & Gynaecology. 20(2): 2006; 207–225.
   PubMed Web of Science ®Google Scholar
• E Chokunonga, AV Ramanakumar, AM Nyakabau. Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997. British Journal of Cancer. 89: 2003; 65–69.
   Web of Science ®Google Scholar
• DM Parkin, F Bray, J Ferlay. Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians. 55: 2005; 74–108.
   PubMed Web of Science ®Google Scholar
• M Odida, R Schmauz, SK Lwanga. Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity. International Journal of Cancer. 99: 2002; 737–741.
   Web of Science ®Google Scholar
• PB Gichangi, J Bwayo, B Estambale. Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS. 17(13): 2003; 1963–1968.
   PubMed Web of Science ®Google Scholar
• RI Anorlu, CO Orakwue, L Oyeneyin. Late presentation of cervical cancer in Lagos: what is responsible?. European Journal of Gynaecological Oncology. 25(6): 2004; 729–732.
   Web of Science ®Google Scholar
• KO Rogo, J Omany, JN Onyango. Carcinoma of the cervix in the African setting. International Journal of Gynecology & Obstetrics. 33: 1990; 249–255.
   Web of Science ®Google Scholar
• ZM Chirenje, S Rusakaniko, V Akino. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998. Central African Journal of Medicine. 46(10): 2000; 264–267.
   Google Scholar
• V Levin, B el Gueddari, A Meghzifene. Radiation therapy in Africa: distribution and equipment. Radiotherapy and Oncology. 52: 1997; 79–83.
   Web of Science ®Google Scholar
• HS Cronje. Screening for cervical cancer in developing countries. International Journal of Gynecology & Obstetrics. 84: 2004; 101–108.
   Web of Science ®Google Scholar
• R Schmauz, P Okong, EM de Villiers. Multiple infections in cases of cervical cancer from a high incidence area in tropical Africa. International Journal of Cancer. 43: 1989; 805–809.
   Web of Science ®Google Scholar
• D Serwadda, MJ Wawer, KV Shah. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. Journal of Infectious Diseases. 180(4): 1999; 1316–1319.
   Web of Science ®Google Scholar
• S Bayo, FX Bosch, S de Sanjose. Risk factors of invasive cervical cancer in Mali. International Journal of Epidemiology. 31: 2002; 202–209.
   PubMed Web of Science ®Google Scholar
• N Chaouki, FX Bosch, N Munoz. The viral origin of cervical cancer in Rabat, Morocco. International Journal of Cancer. 75(4): 1998; 546–554.
   Web of Science ®Google Scholar
• LA Brinton, WC Reeves, MM Brenes. Parity as a risk factor for cervical cancer. American Journal of Epidemiology. 130: 1989; 486–496.
   PubMed Web of Science ®Google Scholar
• A Hildesheim, R Herrero, PE Castle. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. British Journal Cancer. 84(9): 2001; 1219–1226.
   Web of Science ®Google Scholar
• N Munoz, S Franceschi, C Bosetti. Role of parity and human papillomavirus in cervical cancer. The IARC multicentre case-control study. Lancet. 359: 2002; 1093–1101.
   PubMed Web of Science ®Google Scholar
• LS Palacio-Mejía, G Range-Gomez, M Hernandez Avila. Cervical cancer, a disease of poverty: mortality difference between urban and rural areas in Mexico. Salud Pública de México. 45(Suppl 3): 2003; S315–S325.
   Google Scholar
• L Denny. The prevention of cervical cancer in the developing world. BJOG. 112: 2005; 1204–1212.
   Web of Science ®Google Scholar
• SE Hawes, NB Kiviat. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer?. Journal of National Cancer Institute. 94: 2002; 1592–1593.
   Google Scholar
• JS Smith, R Herrero, C Bosetti. Herpes simplex virus-2 as a human papillomavirus cofactor in the aetiology of invasive cervical cancer. Journal of National Cancer Institute. 94: 2002; 1604–1610.
   PubMedGoogle Scholar
• JS Smith, N Muñoz, R Herrero. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the aetiology of invasive cervical cancer in Brazil and the Philippines. Journal of Infectious Diseases. 185: 2002; 324–331.
   PubMed Web of Science ®Google Scholar
• KL Wallin, F Wiklund, T Luostarinen. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. International Journal of Cancer. 101: 2002; 371–374.
   PubMed Web of Science ®Google Scholar
• J Skapinyecz, I Smid, A Horvath. Pelvic inflammatory disease is a risk factor for cervical cancer. European Journal of Gynaecological Oncology. 24(5): 2003; 401–404.
   Web of Science ®Google Scholar
• M Maiman, RG Fruchter, A Sedlis. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynaecologic Oncology. 68: 1998; 233–239.
   PubMed Web of Science ®Google Scholar
• TC Wright Jr, TV Ellerbrock, MA Chiasson. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstetrics and Gynecology. 84(4): 1994; 591–597.
   Web of Science ®Google Scholar
• G La Ruche, B You, I Mensah-Ado. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. International Journal of Cancer. 76: 1998; 482–486.
   Web of Science ®Google Scholar
• M Temmerman, MW Tyndall, N Kidula. Risk factors for human papillomavirus and cervical precancerous lesions: the role of concurrent HIV-1 infection. International Journal Gynecology and Obstetrics. 65: 1999; 171–178.
   PubMed Web of Science ®Google Scholar
• M Moodley, J Moodley, I Kleinschmidt. Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective. International Journal of Gynecological Cancer. 11(3): 2001; 194–197.
   PubMed Web of Science ®Google Scholar
• SE Hawes, CW Critchlow, MA Faye-Niang. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus Type 1 and 2 infections. Journal of Infectious Diseases. 188: 2003; 555–563.
   PubMed Web of Science ®Google Scholar
• ZM Chirenje. HIV and cancer of the cervix. Best Practice and Research Clinical Obstetrics Gynaecology. 19(2): 2005; 269–276.
   PubMed Web of Science ®Google Scholar
• JR Moodley, M Hoffman, H Carrara. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer. 6135: 2006
   Google Scholar
• C Kahesa, J Mwaiselage, HR Wabinga. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BioMed Central Public Health. 8: 2008; 262.
   Web of Science ®Google Scholar
• UNAIDS. AIDS Epidermic Update, 2008.
   Google Scholar
• GA Buga. Cervical cancer awareness and risk factors among female university students. East African Medical Journal. 75(7): 1998; 411–416.
   Web of Science ®Google Scholar
• IO Ajayi, IF Adewole. Knowledge and attitude of out patients’ attendants in Nigeria to cervical cancer. Central African Journal of Medicine. 44(2): 1998; 41–44.
   Google Scholar
• N Wellensiek, M Moodley, J Moodley. Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. International Journal of Gynecological Cancer. 12: 2002; 376–382.
   PubMed Web of Science ®Google Scholar
• RI Anorlu, AAF Banjo, C Odoemhum. Cervical cancer and cervical cancer screening: level of awareness in women attending a primary health care facility in Lagos. Nigeria Postgraduate Medical Journal. 70: 2000; 25–28.
   Google Scholar
• P Gichangi, B Estamble, J Bwayo. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. International Journal of Gynecological Cancer. 13: 2003; 827–833.
   PubMed Web of Science ®Google Scholar
• HL Kidanto, CD Kilewo, C Moshiro. Cancer of the cervix: knowledge and attitudes of female patients admitted at Muhimbili National Hospital, Dar es Salaam. East African Medical Journal. 79: 2002; 467–469.
   PubMedGoogle Scholar
• F Tarwireyi, ZM Chirenje, S Rusakaniko. Cancer of the cervix: knowledge, beliefs and screening behaviours of health workers in Mudzi District in Mashonaland East Province, Zimbabwe. Central African Journal of Medicine. 49: 2003; 83–86.
   PubMedGoogle Scholar
• OA Ayinde, AO Omigbodun. Knowledge, attitude and practices related to prevention of cancer of the cervix among female health workers in Ibadan. Journal of Obstetrics and Gynaecology. 23(1): 2003; 55–58.
   Google Scholar
• SE Anya, DC Oshi, SO Nwosu. Knowledge, attitude, and practice of female health professionals regarding cervical cancer and Pap smear. Nigerian Journal of Medicine. 14(3): 2005; 283–286.
   Google Scholar
• GM Clifford, S Gallus, R Herrero. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 366: 2005; 991–998.
   PubMed Web of Science ®Google Scholar
• SM Kamal, K El Sayed Khalifa. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunology. 28: 2006; 483–496.
   Web of Science ®Google Scholar
• X Castellsagu, J Klaustermeier, C Carla Carrilho. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention. International Journal of Cancer. 122: 2008; 1901–1904.
   Web of Science ®Google Scholar
• M Odida, S de Sanjosé, W Quint. Human papillomavirus type distribution in invasive cervical cancer in Uganda. BioMed Central Infectious Diseases. 8: 2008; 85.
   Web of Science ®Google Scholar
• G Woto-Gaye, C Critchlow, N Kiviat. Cytological detection of cervical cancer in black Africa: what are the perspectives?. Bulletin du Cancer. 83(5): 1996; 407–409.
   Web of Science ®Google Scholar
• RI Anorlu, KA Rabiu, OO Abudu. Cervical cancer screening practices among general practitioners in Lagos, Nigeria. Journal of Obstetrics and Gynaecology. 27(2): 2007; 181–184.
   Web of Science ®Google Scholar
• Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine 2006;24(Suppl 3):S3/71–S3/77.
   Google Scholar
• ZM Chirenje, S Rusakaniko, L Kirumbi. Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries. Bulletin of WHO. 79: 2001; 127–132.
   PubMed Web of Science ®Google Scholar
• AO Omigbodun, OA Ayinde. The management of abnormal cervical smears by Nigerian gynaecologists. International Journal Gynecology Obstetrics. 88: 2005; 340–341.
   PubMed Web of Science ®Google Scholar
• HE Noah, CA Iyoke. Abnormal Pap smears: a comparison of total abdominal hysterectomy and cone biopsy in management. Journal of Obstetrics and Gynaecology. 26(1): 2006; 48–51.
   Google Scholar
• BW Stewart, P Kleihues. World Cancer Report. 2003; IARC Press: Lyon.
   Google Scholar
• H Ashraf. Poor nations need more help to slow growing cancer burden. Lancet. 361: 2003; 2209.
   Web of Science ®Google Scholar
• S Jones. Cancer in the developing world: a call for action. British Medical Journal. 319: 1999; 505–509.
   PubMed Web of Science ®Google Scholar
• C Sepulveda, V Habiyambere, J Amandua. Quality care at end of life in Africa. British Medical Journal. 327: 2003; 209–213.
   PubMed Web of Science ®Google Scholar
• SA Murray, E Grant, A Grant. Dying from cancer in developed and developing countries: lessons from two qualitative interview studies of patients and their caretakers. British Medical Journal. 326: 2003; 368–372.
   PubMed Web of Science ®Google Scholar
• R Harding, J Profrene, PJ Higginson. Palliative care in sub-Saharan Africa. Lancet. 365: 2005; 1971–1977.
   PubMed Web of Science ®Google Scholar
• A Merriman, M Kaur. Palliative care in Africa: an appraisal. Lancet. 365: 2005; 1909–1911.
   Web of Science ®Google Scholar